Rhinovirus and asthma: Challenges and opportunities.
SARS-Cov-2
asthma exacerbations
influenza
rhinovirus
Journal
Reviews in medical virology
ISSN: 1099-1654
Titre abrégé: Rev Med Virol
Pays: England
ID NLM: 9112448
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
revised:
29
10
2020
received:
20
08
2020
accepted:
30
10
2020
pubmed:
21
11
2020
medline:
24
7
2021
entrez:
20
11
2020
Statut:
ppublish
Résumé
Human rhinoviruses (RVs) are the primary aetiological agent of the common cold. Generally, the associated infection is mild and self-limiting, but may also be associated with bronchiolitis in infants, pneumonia in the immunocompromised and exacerbation in patients with pulmonary conditions such as asthma or chronic obstructive pulmonary disease. Viral infection accounts for as many as two thirds of asthma exacerbations in children and more than half in adults. Allergy and asthma are major risk factors for more frequent and severe RV-related illnesses. The prevalence of RV-induced wheezing will likely continue to increase given that asthma affects a significant proportion of the population, with allergic asthma accounting for the majority. Several new respiratory viruses and their subgroups have been discovered, with various degrees of relevance. This review will focus on RV infection in the context of the epidemiologic evidence, genetic variability, pathobiology, clinical studies in the context of asthma, differences with other viruses including COVID-19 and current treatment interventions.
Identifiants
pubmed: 33217098
doi: 10.1002/rmv.2193
pmc: PMC8365703
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2193Informations de copyright
© 2020 The Authors. Reviews in Medical Virology published by John Wiley & Sons Ltd.
Références
J Allergy Clin Immunol. 2016 Dec;138(6):1619-1630
pubmed: 27084403
J Allergy Clin Immunol. 2020 Sep;146(3):555-570
pubmed: 32320734
Lancet. 2010 Sep 4;376(9743):826-34
pubmed: 20816549
Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):5485-90
pubmed: 25848009
J Allergy Clin Immunol. 2008 Oct;122(4):662-668
pubmed: 19014756
J Allergy Clin Immunol. 2007 May;119(5):1105-10
pubmed: 17353039
BMJ. 1993 Oct 16;307(6910):982-6
pubmed: 8241910
Antimicrob Agents Chemother. 2003 Dec;47(12):3907-16
pubmed: 14638501
BMJ. 1995 May 13;310(6989):1225-9
pubmed: 7767192
BMC Genomics. 2016 Jan 25;17:76
pubmed: 26810609
Allergy. 2019 Oct;74(10):1898-1909
pubmed: 30934128
Am J Respir Crit Care Med. 2008 Dec 15;178(12):1271-81
pubmed: 18787220
J Allergy Clin Immunol. 2016 Nov;138(5):1467-1471.e9
pubmed: 27474123
J Infect. 2013 Feb;66(2):163-9
pubmed: 23201152
PLoS Pathog. 2013;9(9):e1003669
pubmed: 24086140
Am J Respir Crit Care Med. 2016 Apr 1;193(7):772-82
pubmed: 26571305
Am J Respir Crit Care Med. 2020 Jan 1;201(1):83-94
pubmed: 31461630
Genetics. 1931 Mar;16(2):97-159
pubmed: 17246615
Virus Evol. 2018 Jan 08;4(1):vex042
pubmed: 29340210
Pediatr Allergy Immunol. 2014 Dec;25(8):796-803
pubmed: 25444257
Respir Med. 2015 Oct;109(10):1280-6
pubmed: 26289742
Am J Respir Crit Care Med. 2012 Feb 1;185(3):281-5
pubmed: 21960534
Am J Respir Crit Care Med. 2020 Jul 15;202(2):202-209
pubmed: 32142615
Antivir Ther. 2002 Mar;7(1):53-65
pubmed: 12008788
Am J Respir Cell Mol Biol. 2017 Jun;56(6):796-803
pubmed: 28257236
Clin Microbiol Rev. 2010 Jan;23(1):74-98
pubmed: 20065326
Trends Ecol Evol. 2008 Apr;23(4):188-93
pubmed: 18295930
N Engl J Med. 2016 May 5;374(18):1793-4
pubmed: 27144864
Am J Med. 2003 Sep;115(4):272-7
pubmed: 12967691
N Engl J Med. 2020 Jun 11;382(24):2372-2374
pubmed: 32302078
Pediatrics. 2009 Mar;123 Suppl 3:S146-50
pubmed: 19221157
Mol Biol Evol. 2006 Oct;23(10):1891-901
pubmed: 16818476
Antiviral Res. 2006 Sep;71(2-3):391-6
pubmed: 16675037
J Allergy Clin Immunol. 2020 Aug;146(2):334-335
pubmed: 32553599
J Allergy Clin Immunol. 2008 May;121(5):1238-1245.e4
pubmed: 18355907
J Allergy Clin Immunol. 2003 May;111(5):1008-16
pubmed: 12743565
Am J Respir Crit Care Med. 2013 Dec 1;188(11):1358-64
pubmed: 23992536
J Gen Virol. 2013 Aug;94(Pt 8):1791-1806
pubmed: 23677786
Antiviral Res. 2000 Sep;47(3):215-20
pubmed: 10974374
Am J Respir Crit Care Med. 2014 Jul 15;190(2):145-54
pubmed: 24937476
J Allergy Clin Immunol. 2005 Jan;115(1):132-8
pubmed: 15637559
Antimicrob Agents Chemother. 2005 Nov;49(11):4492-9
pubmed: 16251287
PLoS Pathog. 2010 Nov 04;6(11):e1001178
pubmed: 21079690
PLoS Pathog. 2013;9(8):e1003520
pubmed: 23935498
Am J Respir Cell Mol Biol. 2008 May;38(5):517-23
pubmed: 18063839
J Allergy Clin Immunol. 2014 Aug;134(2):429-39
pubmed: 24910174
J Allergy Clin Immunol. 2005 Sep;116(3):571-7
pubmed: 16159626
World Allergy Organ J. 2016 Jun 06;9:18
pubmed: 27298711
Genetics. 2002 Jul;161(3):1307-20
pubmed: 12136032
J Allergy Clin Immunol. 2014 May;133(5):1301-7, 1307.e1-3
pubmed: 24698319
Clin Microbiol Rev. 2013 Jan;26(1):135-62
pubmed: 23297263
J Asthma. 2016;53(2):139-45
pubmed: 26369434
Pediatr Infect Dis J. 2009 Apr;28(4):311-7
pubmed: 19258922
J Virol. 1999 Dec;73(12):10489-502
pubmed: 10559367
Pediatrics. 2016 Sep;138(3):
pubmed: 27581858
J Allergy Clin Immunol. 2015 Jun;135(6):1465-73.e5
pubmed: 25794658
Virology. 2014 Jan 5;448:82-90
pubmed: 24314639
Am J Respir Crit Care Med. 2020 Sep 1;202(5):753-755
pubmed: 32649217
Future Virol. 2018 Jul;13(7):505-518
pubmed: 30245735
BMC Evol Biol. 2011 Jul 25;11:220
pubmed: 21787390
Am J Respir Crit Care Med. 2005 Mar 15;171(6):645-51
pubmed: 15591468
Korean J Pediatr. 2014 Jan;57(1):29-34
pubmed: 24578714
Am J Respir Crit Care Med. 2008 Oct 1;178(7):667-72
pubmed: 18565953
Front Microbiol. 2014 May 26;5:226
pubmed: 24904541
J Allergy Clin Immunol. 2003 Apr;111(4):661-75; quiz 676
pubmed: 12704342
Eur Respir J. 2015 Mar;45(3):774-89
pubmed: 25359340
Rev Med Virol. 2021 Jul;31(4):e2193
pubmed: 33217098
Proc Natl Acad Sci U S A. 1991 May 15;88(10):4270-4
pubmed: 1840695
J Allergy Clin Immunol. 2017 Oct;140(4):895-906
pubmed: 28987219